C3-convertase inhibitors for the prevention and treatment of age-related macular degeneration in patients with at risk variants of complement factor H

Details for Australian Patent Application No. 2006330501 (hide)

International Classifications

Event Publications

10 July 2008 PCT application entered the National Phase

PCT publication WO2007/076437 Priority application(s): WO2007/076437

5 April 2012 Application Accepted

Published as AU-B-2006330501

2 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.